Boston MA 骨肉瘤临床试验
9项针对 骨肉瘤的研究正在 Boston及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
招募中2 期
- Dana-Farber Cancer Institute, Boston
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
招募中1/2 期
- Dana-Farber Cancer Institute, Boston
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
招募中3 期
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
SPEARHEAD-3 Pediatric Study
招募中1/2 期
- Dana Farber Cancer Institute, Boston
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
招募中1/2 期
- Dana Farber Cancer Institute, Boston
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
招募中观察性研究
- Dana-Farber Cancer Institute, Boston
Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)
招募中1/2 期
- Dana Farber Cancer Institute, Boston
Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study
招募中2 期
- Dana-Farber Cancer Institute, Boston
Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
招募中1/2 期
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Brigham and Women's Hospital, Boston
其他城市的 骨肉瘤试验
- Memphis, TN10 项研究
- St. Louis, MO10 项研究
- Atlanta, GA10 项研究
- Mountain View, CA8 项研究
- Houston, TX7 项研究
- Chicago, IL7 项研究
- Birmingham, AL7 项研究
- Los Angeles, CA7 项研究
- Tampa, FL6 项研究
- Aurora, CO6 项研究
- Washington, DC6 项研究
- Philadelphia, PA6 项研究
Boston的其他研究
- 乳腺癌110 项研究
- 非小细胞肺癌89 项研究
- 癌症（所有类型）86 项研究
- 转移性癌症63 项研究
- 结直肠癌63 项研究
- 肺癌62 项研究
- 卵巢癌61 项研究
- 前列腺癌61 项研究
- 抑郁症51 项研究
- 子宫内膜癌50 项研究
- 急性髓系白血病45 项研究
- 胰腺癌44 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年9月30日。每项研究自行设定入选标准，由研究团队决定谁能参与。